未登录

M

Maya H Buch

University of Manchester

H指数:68

被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cardiovascular outcomes and safety of SGLT2 inhibitors in rheumatic diseases: a systematic review of evidence predominantly from systemic lupus erythematosus and systemic sclerosis

SGLT2抑制剂在风湿性疾病中的心血管结局与安全性：主要基于系统性红斑狼疮和系统性硬皮病证据的系统综述

Seminars in Arthritis and Rheumatism

IF4.4

2026-10-220

OAAI

Relevance of the 2025 ESC guidelines for the diagnosis and management of myocarditis and pericarditis for systemic autoimmune rheumatic diseases

2025年ESC指南在系统性自身免疫性风湿病中关于心肌炎和心包炎的诊断与管理的相关性

Lancet Rheumatology

IF16.4

2026-09-210

PRE

SA102 Viable Rate of Return for Social Impact Bonds Supporting Research and Development of Gene Therapies for Rare Conditions

SA102 社会影响力债券支持罕见病基因疗法研发的可行收益率

Value in Health

IF6

2025-12-180

PRE

Exploiting a unified vascular framework to predict organ-specific complications and accomplish disease modification in systemic sclerosis

利用统一的血管框架来预测器官特异性并发症并实现系统性硬化病的疾病修饰

The Lancet Rheumatology

IF0

2025-10-140

PRE

Comment on: Risk of venous thromboembolism in people with rheumatoid arthritis: a population-based study in the UK: reply

评论：类风湿关节炎患者静脉血栓栓塞的风险：一项在英国进行的人群研究：回复

IF4.4

2025-09-010

PRE

Including refractory systemic sclerosis-associated GAVE in research agendas

包括难治性系统性硬化病相关GAVE在内研究议程

lancet rheumatology

IF0

2025-08-180

PRE

Risk of venous thromboembolism in people with RA: a population-based study in the UK

类风湿关节炎患者静脉血栓栓塞症的风险：一项英国基于人群的研究

IF4.4

2025-08-012

OAAI

Neither ultrasound synovitis nor clinical-ultrasound phenotypes of established rheumatoid arthritis predict response to targeted therapy

超声滑膜炎或临床-超声表型的已确诊类风湿关节炎均不能预测对靶向治疗的治疗反应。

IF4.4

2025-07-011

OA

The incidence of anti-HMGCR immune-mediated necrotizing myopathy: an Australian and UK retrospective multi-site cohort study

抗HMGCR免疫介导的坏死性肌病发病率：一项澳大利亚和英国回顾性多中心队列研究

IF4.4

2025-05-100

OAAI

Prevalence of cardiovascular disease and its risk factors in rare autoimmune rheumatic diseases: results from a large population-based study

罕见自身免疫性风湿病中心血管疾病及其危险因素的患病率：一项基于大型人群研究的成果

IF4.4

2025-04-280

PRE

An update on the integrated safety analysis of filgotinib in patients with moderate to severe active rheumatoid arthritis over a median of 4.3 years

关于filgotinib在中等至重度活动性类风湿关节炎患者中的综合安全性分析的中位4.3年更新。

IF4.4

2025-04-280

PRE

Health literacy and disease, clinical, functional and management outcomes in inflammatory arthritis: a systematic literature review

健康素养与炎症性关节炎的疾病结局、临床结局、功能结局和管理结局：一项系统文献综述

IF4.4

2025-04-280

PRE

Long-term efficacy of filgotinib monotherapy and combination therapy: interim results from a post hoc analysis of the FINCH 4 study

filgotinib单药治疗和联合治疗的长效性：FINCH 4研究事后分析的中期结果

IF4.4

2025-04-280

PRE

Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research Cohort

欧洲硬皮病试验与研究队列中系统性硬化症原发性心脏受累及慢性心力衰竭的评估

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2025-02-260

OAAI

Gyoerfi, Andrea-Hermina; Filla, Tim; Polzin, Amin; Tascilar, Koray; Buch, Maya; Troebs, Monique; Matei, Alexandru-Emil; Airo, Paolo; Balbir-Gurman, Alexandra; Kuwert, Frederic; Mihai, Carina; Kabala, Anna; Grasshoff, Hanna; Callaghan, Julia; Isomura, Yohei; Mansour, Jennifer; Spierings, Julia; Tennoe, Anders Heiervang; Selvi, Enrico; Riccieri, Valeria; Hoffmann-Vold, Anna-Maria; Bergmann, Christina; Schett, Georg; Hunzelmann, Nicolas; van Laar, Jacob M.; Saketkoo, Lesley Ann; Kuwana, Masataka; Siegert, Elise; Riemekasten, Gabriela; Distler, Oliver; du Four, Tessa; Smith, Vanessa; Truchetet, Marie-Elise; Distler, Joerg H. W.; EUSTAR Collaborators

Baseline synovitis-tenosynovitis is associated with remission in early rheumatoid arthritis, but discordance with disease activity is a changeable state

基线滑膜炎-腱鞘滑膜炎与早期类风湿关节炎的缓解相关，但与疾病活动度的不一致是一种可变状态。

IF4.4

2025-02-170

OA

High throughput multiplex immunoassays stratify patients according to symptom burden across the anti-Ro positive systemic autoimmune rheumatic disease spectrum

IF3.1

2024-11-280

OA

Protein quantitative trait loci identifies genetic biomarkers of proteins associated with measures of myocardial fibrosis in new-onset, treatment naive rheumatoid arthritis

EUROPEAN HEART JOURNAL

IF35.6

2024-10-280

PRE

Barriers to, Facilitators of, and Interventions to Support Treat-to-Target Implementation in Rheumatoid Arthritis: A Systematic Review

类风湿关节炎达标治疗实施的障碍、促进因素及干预措施：系统综述

ARTHRITIS CARE & RESEARCH

IF3.3

2024-09-040

PRE

Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases

NATURE REVIEWS RHEUMATOLOGY

IF32.7

2024-09-021

PRE

A PRACTICAL FRAMEWORK FOR INDIVIDUALIZED BENEFIT/RISK ASSESSMENT AND CLINICAL DECISION-MAKING ON TREATMENT WITH TOFACITINIB

一种用于托法替尼治疗个体化获益/风险评估和临床决策制定的实用框架

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2024-06-010

PRE